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Abstract
Background: The life cycle of human immunodeficiency virus type-1 (HIV-1) makes possible the realization of
regulatory strategies that can lead to complex dynamical behavior of the system. We analyze the strategy which is
based on two feedback mechanisms, one mediating a positive regulation of the virus replication by Tat protein via
the antitermination of the genomic RNAs transcription on TAR (transactivation responsive) element of the proviral
DNA and the second mechanism providing a negative regulation of the splicing of the full-length (9 kb) RNAs and
incompletely spliced (4 kb) RNAs via their transport from the nucleus to the cytoplasm. Although the existence of
these two regulatory feedback loops has been considered in other mathematical models, none of them examined
the conditions for the emergence of complex oscillatory patterns in the intracellular dynamics of viral components.
Results: We developed a mechanistic mathematical model for the Tat-Rev mediated regulation of HIV-1 replication,
which considers the activation of proviral DNA transcription, the Tat-specific antitermination of transcription on TAR-
element, resulting in the synthesis of the full-length 9 kb RNA, the splicing of the 9 kb RNA down to the 4 kb RNA
and the 4 kb RNA to 2 kb RNA, the transport of 2 kb mRNAs from the nucleus to the cytoplasm by the intracellular
mechanisms, the multiple binding of the Rev protein to RRE (Rev Response Element) sites on 9 kb and 4 kb RNA
resulting in their export to the cytoplasm and the synthesis of Tat and Rev proteins in the cytoplasm followed by
their transport into the nucleus. The degradation of all viral proteins and RNAs both in the cytoplasm and the
nucleus is described. The model parameters values were derived from the published literature data. The model was
used to examine the dynamics of the synthesis of the viral proteins Tat and Rev, the mRNAs under the intracellular
conditions specific for activated HIV-1 infected macrophages. In addition, we analyzed alternative hypotheses for the
re-cycling of the Rev proteins both in the cytoplasm and the nuclear pore complex.
Conclusions: The quantitative mathematical model of the Tat-Rev regulation of HIV-1 replication predicts the
existence of oscillatory dynamics which depends on the efficacy of the Tat and TAR interaction as well as on the
Rev-mediated transport processes. The biological relevance of the oscillatory regimes for the HIV-1 life cycle is
discussed.
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Background
Periodic oscillations are observed in biological systems
across multiple levels of their organization, including a sin-
gle cell level [1-4]. Some researchers view the individual
cell as an oscillator [5]. The oscillatory regimes result from
the system regulation mechanisms based upon feedback
loops [6]. The oscillatory dynamics of genes expression is
widely observed in prokaryotic and eukaryotic cells at the
molecular-genetic level. The underlying regulation is con-
sidered to be a major mechanism for coordinating various
intracellular processes. The specific examples include the
oscillations in the NF-B level during the immune
response development [7-9], the Hes1 and Hes7 proteins
regulating the somite segmentation during the embryonic
development of vertebrates [10,11], the p53 protein con-
trolling the cell apoptosis (a programmed cell death) [12],
etc. The key role of the negative regulatory feedback loops
in the emergence of oscillations has been pointed out in a
number of theoretical studies of natural and artificial gene
networks [13-17].
The life cycle of human immunodeficiency virus type-1
(HIV-1) makes possible the realization of regulatory stra-
tegies that can lead to qualitatively different outcomes.
For example, a high level of virus production can lead to
the activation of apoptosis resulting in the cell death or
to a persistent production of the infectious virus particles
over a period of several months [18]. One of the mechan-
isms enabling high level production of virus particles is
the positive regulatory mechanism of the virus replication
by Tat protein, with its mRNA being the product of an
alternative splicing of HIV-1 genomic RNA that belongs
to the 2 kb classes of mRNAs [19]. The production of
Tat protein leads to an augmentation of full-length geno-
mic RNA transcription by at least 25- to 100 fold [20-23].
However, for the production of virus particles both the
synthesis and the transport from the nucleus to the cyto-
plasm of the full-length unspliced 9 kb RNA is needed
because this full-length RNA represents the viral genome
and the mRNA for the Gag and Gag-Pol proteins synth-
esis. The availability of the full-length viral genomic
RNAs and the Gag proteins in the cytoplasm is required
for the budding and the final assembly of the virions (for
recent review, see [24]). As the eukaryotic cells have no
mechanisms for transporting the intron-containing viral
RNA out of the nucleus, the transport is provided by the
virus via the Rev-mediated mechanism. The Rev protein
is synthesized from the completely spliced viral mRNA
[25], which is exported from the nucleus to the cyto-
plasm by endogenous cellular mechanisms [19]. The Rev
protein contains the nuclear localization sequence (NLS)
or the nuclear export sequence (NES), which control the
shuttling of Rev between the nucleus and the cytoplasm
[26-28]. Its appearance in the nucleus followed by the
interaction with the Rev-responsive element (RRE) leads
to the assembly of a high-affinity complex on unspliced-
(9 kb) and incompletely spliced (4 kb) viral mRNA [28]
and the export of the above classes of the viral mRNAs
out of the nucleus. This results in a down-regulation of
the generation of the completely spliced mRNAs and
therefore, of the overall synthesis of the Rev and Tat pro-
teins [29].
The availability of two regulatory loops, one represent-
ing a positive feedback of the activation of HIV-1 tran-
scription mediated by Tat protein and the second one
being a negative feedback loop regulating the Tat and
Rev mRNA synthesis, sets up the prerequisite for the
emergence of oscillatory regimes in the production of
virus particles. The mathematical models of the intracel-
lular HIV-1 kinetics [30-34] developed so far consider
the above regulatory feedback loops and reproduce
some specific experimental data on the kinetics of
HIV-1 replication. However, the existence of an oscilla-
tory dynamics in the production of the viral components
in an infected cell has not been examined (or discussed)
yet.
We develop a mathematical model for the Tat-Rev
mediated regulation of HIV-1 replication to examine the
dynamics of the accumulation of the Tat and Rev pro-
teins and the viral RNA in an infected macrophage, per-
sistently producing the virus particles. Two specific
hypotheses of the re-cycling (nuclear import/export
cycle) of HIV-1 Rev protein are considered. The first
hypothesis reflects a widely accepted view that the Rev
protein is released from the nuclear export complex in
the cytoplasm followed by its binding to importin-b
(see, e.g. [19]). The second hypothesis is based on the
evidence suggesting that the Rev protein returns into
the nucleus directly at the nuclear pore complex without
the exit to the cytoplasm [35,36].
The mathematical model calibrated using published
experimental data on the processes underlying the func-
tioning of the Tat-Rev regulatory loops predicts the
existence of oscillatory dynamics which depends on the
efficacy of the interaction between the Tat protein and
TAR and on the transport kinetics regulated by the Rev
protein.
Model
The mathematical model of the intracellular HIV-1
replication is specified using the biochemical systems
formalism [3]. Two elementary types of reactions are
considered, the bimolecular and the monomolecular
ones. In this section we apply some standard notation to
represent the chemical reactions. The following repre-
sentation is used for a bimolecular reaction:
A + B ⇔ C : k1, k2.
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In the above notation, A, B and C refer to the concen-
tration of chemical products whereas k1 and k2 denote
the rate constant of the forward and reverse reactions.
According to the Law of Mass Action [3], the following
system of ordinary differential equations (ODEs) corre-
sponds to bimolecular reaction.
dA(t)
dt
=
dB(t)
dt
= −dC(t)
dt
= −k1A(t)B(t) + k2C(t)
The equations describe the local rates of changes in the
concentrations of the reactants A,B,C in a fixed volume.
Following the standard paradigm, an instantaneous mix-
ing of the products in the given volume is assumed.
The monomolecular reaction is specified using the fol-
lowing notation:
[a] · A → [b1] · B1 + ... + [bn] · Bn : k.
Here A, Bi denote the chemical products concentra-
tions, k is the reaction rate constant, and a={0,1}, bi≥0
are the stoichiometric coefficients. The monomolecular
reaction is mathematically described with the following
system of ODEs
dA(t)
dt
= −akA(t), dBi(t)
dt
= bikA(t), i = 1, ..., n,
which determines the local rates of changes in the
concentrations of the reactants in a fixed volume. To
simplify the notation of the mono-molecular reactions,
we will omit the stoichiometric coefficient of 1. The
value of a = 0 suggests that the reactant A is not trans-
formed in the reaction.
Elementary subsystems of the model
The biochemical model of the Tat-Rev mediated regula-
tory network of HIV-1 replication can be decomposed
into a set of elementary subsystems. They are specified
according to the scheme of the model of HIV-1 replica-
tion shown in Figure 1. The specific modules are
described below with the corresponding parameters
listed in table 1.
1. The initiation of transcription from the HIV-1 pro-
viral LTR-promoter <LTR_prom_HIV1> leading to the
formation of the elongation complex <TAR_RNApol - II
elong> that is prone to termination at TAR element is
represented by:
[0] · LTR prom HIV1 → TAR RNApol − II elong : ktranscr,ini × proV.
Here, ktranscr, ini denotes the rate constant of the tran-
scription initiation and proV is the number of the pro-
viral DNA genomes in the cell.
2. The passage of the TAR-element by RNA polymer-
ase II. It is assumed that with a probability l the RNA
polymerase II is terminated leading to the formation of
short RNA <microRNA>, whereas the value (1-l) gives
the probability of the formation of the elongation com-
plex <DNAunit_RNApol-II_elong_(1)>, that escaped the
termination at the TAR element:
TAR RNApol−II elong → [1−λ]·DNAunit RNApol−II elong (1)+[λ]·microRNA : kdelay.
Here, the parameter kdelay is the constant rate of
RNA-ploymerase II exit from the pausing period at the
TAR element.
3. Tat-dependent antitermination of the transcription
at the TAR element is described using the following two
reactions:
TAR RNApol − II elong + protTat nuc ⇔ Tat TAR : kass,Tat TAR, kdis,Tat TAR
Tat TAR → DNAunit RNApol − II elong (1) + protTat nuc : kantiterm.
The first reaction describes the interaction of the
complex <TAR_RNApol-II_elong> prone to termination
at the TAR element with the nuclear fraction of the Tat
protein <protTat_nuc> resulting in the formation of the
<Tat_TAR> complex. The second reaction takes into
account the Tat-dependent antitermination leading to
the creation of the elongation complex and the release
of Tat protein. The parameters kass,Tat_TAR и kdis,Tat_TAR
represent the constant rates for association and dissocia-
tion of the Tat protein with the TAR element, respec-
tively; kantiterm is the rate constant of the transcriptional
antitermination by Tat protein at the TAR-element.
4. To simulate the delay in the synthesis of 9 kb
RNAs, we used the chain of nDNAunit reactions to
describe the transcription elongation from the TAR ele-
ment to the transcription terminator:
DNAunit RNApol − II elong (i) → DNAunit RNApol − II elong (i + 1) : ktranscr,elong,i,
i = 1, ..., nDNAunit ,
where DNAunit_RNApol-II_elong_(i) denotes the
number of the elongating complexes at the i-th segment
of the proviral DNA; ktranscr,elong,i is the transcription
elongation rate constant at the i-th segment. It is
assumed that the lengths of the segments and therefore,
the transcription rates are the same.
5. The transcription termination finalizing the elonga-
tion of the last (nDNAunit+1)-th segment of the proviral
DNA and the release of the precursor molecule of the
nuclear 9 kb RNA <pre-9 kb-RNA_nuc> is represented
as follows:
DNAunit RNApol − II elong (nDNAunit + 1) → pre − 9kb − RNA nuc : ktranscr,term
with ktranscr,term denoting the transcription termination
rate constant of the 9 kb RNA.
6. The maturation of the 9 kb mRNA primary tran-
script into the mature 9 kb mRNA form <9 kb-RNA_-
nuc> is modelled by:
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pre − 9kb − RNA nuc → 9kb − RNA nuc : kmodif
where kmodif is the rate constant of the primary 9 kb
RNA maturation.
7. Splicing of the 9 kb RNA leading to the formation
of 4 kb RNA <4 kb - RNA_nuc> in the nucleus is repre-
sented by:
9kb − RNA nuc → 4kb − mRNA nuc : ksplicing,94
Rev (i) 9kb − mRNA nuc → Rev (i) 4kb − mRNA nuc : ksplicing,94, i = 1, ..., nRev
Here ksplicing,94 is the splicing rate constant from 9 kb
to 4 kb mRNAs.
8. Alternative splicing of the 4 kb RNA to 2 kb
mRNAs which encode the Tat <2 kb-RNA_Tat_nuc>
and Rev <2 kb-RNA_Rev_nuc> proteins is described by
4kb−RNA nuc → [δ4,Tat]·2kb−RNA Tat nuc+[δ4,Rev]·2kb−RNA Rev nuc : ksplicing,42.
We denote by ksplicing,42 the rate constant for splicing
of 4 kb mRNA to 2 kb; and the parameters δ4,Tat, δ4,Rev
stand for the fractions of 2 kb RNAs 2 kb-RNA_Tat_nuc
and 2 kb-RNA_Rev_nuc produced by an alternative spli-
cing of 4 kb mRNA.
9. Transport of 2 kb mRNAs into the cytoplasm is
modelled by the equation:
2kb − RNA Xxx nuc → 2kb − RNA Xxx cyt : ktransp,2kb−mRNA Xxx,Xxx ∈ {Tat,Rev}
The concentration of 2 kb mRNAs encoding Tat and
Rev in cytoplasm is denoted by <2 kb-RNA_Xxx_cyt>
and ktransp, 2 kb-RNA_Xxx represents the nuclear export
rate constant for 2 kb RNA for the Tat and Rev
proteins.
10. The synthesis of the Tat and Rev proteins in the
cytoplasm is described as a chain of reactions, considering
the initiation, elongation and termination of translation:
[0]2kb − RNA Xxx cyt → 2kb − RNA Xxx transl − elong (1) : ktransl,ini,Xxx
2kb − RNA Xxx transl − elong (i) → 2kb − RNA Xxx transl − elong (i + 1) : ktransl,elong,i,
i = 1, ..., nXxx,
2kb − RNA Xxx transl − elong (nXxx + 1) → prot Xxx cyt : ktransl,term,nXxx+1,Xxx ∈ {Tat,Rev}.
Here ktransl,ini,Xxx is the initiation of translation rate
constant, ktransl,elong,i is the translation elongation rate
Figure 1 The scheme of Tat-Rev mediated regulatory circuit of HIV-1 replication used for the model. The numbering in parentheses
corresponds to the numbering of the corresponding subsystem of the biochemical model presented in the section “Elementary subsystems of
the model”. The description of the subsystems and their respective variables is given in the text.
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constant for i-th segment and ktransl,term,nXxx+1 stands for
the translation termination rate constant for (nXxx+1)-th
segment. The first reaction describes the initiation of
the Tat and Rev proteins translation in the cytoplasm
resulting in the formation of the elongation complex <2
kb - RNA_Xxx_transl-elong_(1)>. The next nXxx reac-
tions consider the translation elongation for the Tat and
Rev proteins. The use of the reactions chain serves to
reproduce the delay in the synthesis of Tat and Rev.
The set <2 kb - RNA_Xxx_transl-elong_(i)> characterizes
the number of elongation complexes on i-th segment of
the viral mRNAs. The last reaction describes the transla-
tion termination associated with the formation of Tat
and Rev. <prot_Xxx_cyt> denotes the amount of the Tat
and Rev proteins in the cytoplasm.
11. The transport of the Tat and Rev proteins from the
cytoplasm to the nucleus is modelled by the equation:
prot Xxx cyt → prot Xxx nuc : ktranp,prot Xxx,Xxx ∈ {Tat,Rev},
where <prot_Xxx_nuc> is the abundance of Tat and
Rev in the nucleus, and ktransp,Xxx is the protein-specific
rate constant for transport from the cytoplasm to the
nucleus for Tat and Rev.
12. The formation of the complexes of the Rev pro-
teins with 9 kb RNAs and 4 kb RNAs is described as a
sequence of nRev reactions resulting in the production of
nRev-th complex. It is assumed that the complexes of
Rev with 9 kb- and 4 kb RNAs can take place both in
the nucleus and the cytoplasm. The corresponding set
of equations reads:
Xkb − RNA yyy + prot Rev yyy ⇔ Rev (1) Xkb − RNA yyy : kass,Rev (1) X yyy, kdis,Rev (1) X yyy
Rev (i) Xkb − RNA yyy + prot Rev yyy ⇔ Rev (i + 1) Xkb − RNA yyy : kass,Rev (i+1) X yyy, kdis,Rev (i+1) X yyy,
i = 1, ...,nRev − 1,X ∈ {9, 4}, yyy ∈ {nuc, cyt}.
The variables and the parameters have the following
meaning: <Rev_(i)_X kb-RNA_yyy> is the number of i-
molecules containing complexes of the Rev proteins
with either 4 kb- or 9 kb RNAs in the nucleus and in
the cytoplasm, respectively; kass,Rev_(i+1), kdis,Rev_(i+1) - are
the association- and dissociation rate constants for Rev
binding with 4 kb RNA and 9 kb RNA at the stage of
the (i+1)- meric complex formation in the nucleus or
the cytoplasm.
13. Rev-dependent transport of 9 kb RNA and 4 kb
RNA from the nucleus <Rev_(i)_X kb-RNA_nuc> to the
cytoplasm <X kb-RNA_cyt> followed by the release of
the Rev protein in the nucleus (nuclear pore complex)
and in the cytoplasm is described by the equations
Rev (i) Xkb − RNA nuc → Xkb − RNA cyt + [γi] · prot Rev nuc + [i − γi] · prot Rev cyt : ktransp,X,i,
i = 1, ...,nRev,X − 1,X ∈ {9, 4}.
Here, kiransp,X,i stands for the rate constant of the
nuclear export of the i-meric complex of Rev with 9 kb-
or 4 kb RNA; gi is the fraction of the Rev protein,
released from the i-meric complex in the nuclear pore
complex compartment; (i-gi) is the fraction of Rev,
released from the i-meric complex in the cytoplasm.
14. The degradation of the 9 kb-, 4 kb-, 2 kb RNAs in
the nucleus and cytoplasm is described by the following
first order reactions:
Xkb − RNA yyy → ∅ : kdegr,Xkb−RNA yyy,
2kb − RNA yyy → ∅ : kdegr,2kb−RNA yyy,
Rev (i) Xkb − RNA yyy → [γi] · prot Rev nuc : kdegr,Rev (i) Xkb−RNA yyy,
prot − Xxx yyy → ∅ : kdegr,prot−Xxx yyy,
i = 1, ...,nRev,X − 1,X ∈ {9, 4},Xxx ∈ {Tat,Rev}, yyy ∈ {nuc, cyt}.
Here kdegr,X kb-RNA_yyy are the 9 kb- and 4 kb RNAs
degradation rate constants in the nucleus and cyto-
plasm; kdegr,prot_yyy are the protein specific degradation
rate constants for the Tat and Rev proteins; and kdegr,
Rev_(i)-RNA_yyy stand for the degradation rate constants for
9 kb and 4 kb RNAs in the nucleus and cytoplasm in
the i-meric complex with the Rev protein.
Assembly of the model from basic subsystems and the
computational method
The overall change rates for all the species concentra-
tions considered in the model are calculated by sum-
ming up the local rates over all elementary subsystems
which consider the respective reactants. To solve
numerically the initial value problem for the model
equations we used the Gear’s method based on back-
ward differentiation formulae [37] implemented in For-
tran. The source code is available upon request to the
first author.
Estimation of the model parameters
The estimation of the model parameters was carried out
by using published experimental data or some funda-
mental biological considerations when the specific data
were not available.
Transcription: The transcription elongation rate in
eukaryotic cells ranges from 25 to 60 nucleotides/sec
[38-40]. For HIV-1 a similar estimate of about 33
nucleotides/sec was obtained using the reporter con-
struct with 70 copies of it integrated at specific tran-
scription site of the viral genome [41,42]. We assumed
that the basal transcription rate starting from the HIV-1
promoter in non-activated cells is about 40 nucleotides/
sec, whereas the transcription initiation is about 0.25
events per minute.
The exit rate of RNA-Pol-II from transcription elonga-
tion pausing is described by parameter kdelay. We esti-
mated the parameter value to be kdelay = 1 min
-1,
assuming that the duration of the pausing is about 1
min. The underlying arguments are based on the view
that the pausing time should be longer then the time of
the transcription through the TAR element by RNA-
polymerase II (RNApol-II) without the pausing, which
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ranges from 1 to 2 seconds. The later estimate results
from the base length of the TAR element being 59
nucleotides and the elongation rate of about 25-60
bases/sec [38,40]. In the absence of the Tat protein,
RNApol-II located at the TAR element can sponta-
neously leave the pausing and either continue the tran-
scription, or terminate it. We assumed the ratio of
1:100, i.e. in the absence of Tat the pausing leads to the
transcription termination for about 99 RNApol-II mole-
cules out of one hundred. The RNA polymerase II can
also exit the pausing and continue the transcription in
the presence of the Tat protein due to its interaction
with the secondary structure of the TAR element on the
synthesized RNA. The availability of Tat in the nucleus
activates the synthesis of 9 kb RNA by up to 25- to
100-fold [23,43,44].
The antitermination efficacy in the model is described
by the parameter kTat-antiterm,TAR. We used the estimate
kTat-antiterm,TAR = 60 min
-1. The parameters kass,Tat-TAR
and kdis,Tat-TAR, represent the binding and dissociation
rate constants for the Tat protein with the secondary
structure of the partially synthesized RNA at the TAR-
element region, respectively (see Table 1). The published
data provide the estimate for the ratio Kdis,Tat=kdis,Tat-
TAR/kass,Tat-TAR with the range 100-400/μM [45,46]. In
the computations we assumed the dissociation rate con-
stant to be kdis,Tat-TAR= 1 min
-1, which was derived
using the values Kdis,Tat = 100/μM and the volume of
the nucleus of 100 μm3 (calculated from [47]).
Splicing: According to the experimental data
[38,48,49], the splicing of the pre-mRNAs takes place
during the transcription with the characteristic time of
about 5 to 10 min and is not dependent on the introns
size.
Transport: The transport of 2 kb mRNA from the
nucleus to the cytoplasm is carried out by endogenous
cellular mechanisms. According to the available data
[50,51], the active transport through the nuclear pore is
a relatively fast process (10 to 100 molecules per the
pore per second) and therefore, can be described as a
single event via the monomolecular reaction equation.
The transport of 9 kb- and 4 kb RNAs out of the
nucleus is mediated by Rev-dependent mechanism.
According to the available data [28,52,53] the binding of
the Rev protein to the RRE site of the intron-containing
HIV-1 mRNA takes place sequentially and the formed
oligomeric complex Rev/RRE can contain up to 12
molecules of the Rev protein.
The transport of Tat and Rev back to the nucleus is
mediated by the endogenous cellular mechanisms
through the nuclear localization sequence (NLS) signal.
The transport kinetics of Tat was characterized by the
kinetics of heterologous protein bound to the Tat NLS
under in vivo conditions [54]. The experimental data
suggest that the protein specific rate constant of the
nuclear import is 0.303 ± 0.099 min-1. We assumed in
the model that the Tat and Rev nuclear import rate
constants are similar and of 0.347 min-1.
Table 1 Summary of the model parameters used for numerical simulations of HIV-1 replication
Subsystem
number
Parameter notation Units Reference value Reference
1 ktranscr,ini Transcription initiation/
(min genome)
0.25 (for non-
activated cell)
[64,65]
25 (for activated
cell)
LTR prom HIV1 elements/nucleus 1 assigned
2 kdelay 1/min 1 assigned
l 0.99 estimated
3 kass,Tat TAR elements/(nucleus min) 0.0017 [45]
kdis,TAT TAR 1/min 1
kantiterm 1/min 60 assigned
4 ktranscr,elong,i, i = 1, ...,nDNAunit 1/min 5.33 derived
nDNAunit dimensionless 20 assigned
5 ktranscr,term 1/min 60 assigned
6 kmodif 1/min 60 assigned
7 ksplicing,94 1/min 0.0415 [38,48,49]
8 ksplicing,42 1/min 0.0415
δ4,Tat dimensionless 0.115 Estimated from [83]
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Translation: The published data [55,56] suggest that
the average ribosome density per codon in eukaryotic
cells is 0.017. Taking into account the length of Tat/Rev
mRNA of about 2000 bases, the number of available
ribosomes at this segment can be estimated to be about
11. The translation elongation rate of mRNA depends
on the initiation rate. In the model we assumed the
initiation rate to be about 10 per min, which suggests
that the translation elongation rate constant is about 30
nts/sec.
mRNA stability: The data by [57] suggest that the
stability of the HIV-1 mRNA in both compratments
(the nucleus and the cytoplasm) is about the same
with the half-life for the Tat mRNA being 4 to
5 hours and that of Rev ranging from 4 to 13 hours
[58,59].
Table 1 Summary of the model parameters used for numerical simulations of HIV-1 replication (Continued)
δ4,Rev dimensionless 0.115
9
ktransp,2kb−mRNA Xxx,
Xxx ∈ {Tat,Rev} 1/min 0.0767 [27]
10 ktransl,ini,Xxx,Xxx ∈ {Tat,Rev} 1/min 10 assigned
ktransl,elong,i,Xxx ∈ {Tat,Rev} 1/min 18 derived
ktransl,term,nXxx+1,Xxx ∈ {Tat,Rev} 1/min 60 assigned
nXxx,Xxx ∈ {Tat,Rev} dimensionless 20 assigned
11 ktransp,prot Xxx,Xxx ∈ {Tat,Rev} 1/min 0.347 [54]
12
kass,Rev (i) X nuc,
i = 1, ..., nRev,X ∈ {9, 4} copy/(nucleus min) 0.59
kass,Rev (i) X cyt,
i = 1, ..., nRev,X ∈ {9, 4} [28]
kdis,Rev (i) X nuc,
i = 1, ..., nRev,X ∈ {9, 4}
1/min 8.4
kdis,Rev (i) X cyt,
i = 1, ..., nRev,X ∈ {9, 4}
13 ktransp,X,1,X ∈ {9, 4} 1/min 0 [82]
ktransp,X,i,
i = 2, ...,nRev,X ,X ∈ {9, 4}
1/min 0.0767 [27]
γi, i = 1, ...,nRev,X dimensionless 12 Quantified following the recycling in the
nuclear pore hypothesis
12,13 nRev,X,X ∈ {9, 4} dimensionless 12 [28,52,53]
14 kdegr,Xkb−mRNA yyy,X ∈ {9, 4},
yyy ∈ {nuc, cyt}
kdegr,2kb mRNA Tat yyy,
yyy ∈ {nuc, cyt} 1/min 0.0029 [58]
kdegr,2kb mRNA Re v yyy,
yyy ∈ {nuc, cyt}
kdegr,prot−Xxx nuc,
Xxx ∈ {Tat,Rev} 1/min 0.000722 [60]
kdegr,prot−Xxx cyt,Xxx ∈ {Tat,Rev} 1/min 0.00289
Auxiliary
parameters
rtranscr,elong nts/min 2400 [38,40]
rtranscl,elong nts/min 1800 [55,56]
Nucl_9 kb-RNA nucl 9000 [25]
Nucl_2 kb-mRNA nucl 2000
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Stability of proteins: The half-life of Rev is assumed
in the model to be about 4 hours and 16 hours in the
cytoplasm and the nucleus, respectively [60].
The parameters of the mathematical model used in
computations are summarized in Table 1.
Basic model of the Tat-Rev regulatory circuit
The basic model of the Tat-Rev regulatory circuit is
composed of subsystems referred to in Table 1 as 1-11,
12 (for the nucleus) and 13. It is assumed that Rev pro-
tein binding to the RRE element on 9 kb and 4 kb
RNAs terminates their splicing to the 2 kb mRNA
(Figure 1), in agreement with the available data [61-63].
As the basic model neglects the formation of the com-
plexes of the de novo synthesized Rev proteins with the
9 kb- and 4 kb RNA molecules in the cytoplasm, sub-
system 12 is applied to the nuclear mRNAs only.
There is no clear view on the re-cycling (import/
export cycle) mechanisms for the Rev protein. It is
considered that the release of Rev from the nuclear
export complex can take place in the cytoplasm
(hypothesis 1) [19] as well as in the nucleus (hypothesis
2) [35,36]. The scheme of the Rev recycling for the two
hypotheses is shown in Figure 2. We analyze the impli-
cations of hypotheses 1 and 2. The basic model imple-
ments the first hypothesis, i.e. the Rev protein is
considered to be released from the nuclear export com-
plex in the nuclear pore compartment to return to the
nucleus. Therefore, in subsystem 13 zero values of the
following parameters are used gi = 0, i = 1,...,12. The
analysis of the second hypothesis would require non-
zero values to be assigned to gi.
Results
Synthesis of viral components in non-activated and
activated cells
Consider a non-activated cell with one proviral HIV-1
genome. The basal level of the transcription initiation at
Figure 2 Schematic representation of Rev-mediated transport of intron-containing 4 kb and 9 kb RNAs and of the Rev protein
recycling. (A) - hypothesis 1 for the Rev recycling at the nuclear pore complex; (B) - hypothesis 2 for the Rev recycling in the cytoplasm. RRE -
Rev binding site on 4 kb and 9 kb RNAs; Crm1, RanGTP, RanGDP, Importin - are the major cellular factors mediating the RNA export and import
of RNA.
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the viral promoter site is about 0.25 per min (see Sec-
tion on Parameter estimation). The model computations
predict that for the parameter values listed in Table 1 a
steady state pattern is established.
According to [64], in an activated cell the concentra-
tion of active NF-B molecules sets up to the level that
is enough to increase the initiation of transcription rate
at the viral promoter site to about 25 initiations per min
as estimated in [65]. The model computations predict
an oscillatory functioning mode for the corresponding
parameter values (Table 1). The dynamic details of the
oscillatory pattern are shown in Figure 3.
It should be noted that the oscillatory pattern in
Figure 3 appears as a limit cycle. The period of the cycle
is rather long being of more than 150 hours. The ampli-
tude of the oscillations in the concentrations of the Tat
and Rev proteins and the 2 kb RNAs encoding Tat and
Rev over one period is quite significant. The simulations
further predict that the 2 kb RNA molecules are present
in trace amounts and are amenable to detection during
a rather short time window of about 10 hours as com-
pared to the cycle period.
The above solutions were computed under the
assumption that the Rev-regulated export of 9 kb RNA
and 4 kb RNA from the nucleus to the cytoplasm does
not lead to the exit of the Rev protein from the nucleus
to the cytoplasm, which is in agreement with the
hypothesis of the Rev recycling in the nuclear pore com-
plex [36]. In addition, we did not consider the formation
of the complexes of the de novo synthesized Rev pro-
teins with the 9 kb RNA and 4 kb RNA molecules in
the cytoplasm compartment. As the corresponding pro-
cesses are poorly understood for real systems, we exam-
ine their impact on the kinetics of the viral molecules
synthesis in the next section.
Impact of the nuclear export of the HIV-1 Rev protein to
the cytoplasm on the kinetics of viral components
synthesis in an activated cell
There are some data suggesting that the Rev protein
bearing the nuclear localization sequence (NLS) and the
nuclear export sequence (NES) can shuttle between the
nucleus and the cytoplasm [26,27]. The available data
on the mechanisms of the Rev-mediated transport of
the intron-containing viral RNA [19,36] are not defini-
tive enough to select one out of the two hypotheses on
the Rev recycling mechanism.
As indicated in the previous section, in the basic
model we consider the hypothesis on the Rev recycling
in the nuclear pore complex as the preferred one for
which most of the analysis is made [36]. However, the
possibility of Rev leaving the nucleus for the cytoplasm
of the cell can not be completely excluded. In addition,
there are no reasons to completely rule out the
Figure 3 Kinetics of the viral RNA and proteins synthesized in an activated cell with one provirus copy. A - the abundance of free Tat
molecules (not bind to RNA at the TAR element) (blue) and Rev molecules (not bind to 9 kb RNA and 4 kb RNA) (pink) in the nucleus; B - the
abundance of free Tat and Rev proteins in the cytoplasm (their kinetics is identical as the corresponding model parameters for these two
proteins are identical and the nuclear export of Rev to the cytoplasm is not considered); C - the abundance of 2 kb RNA molecules in the
nucleus (blue) and cytoplasm (pink) encoding the Tat and Rev proteins.
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interaction of the Rev protein with 9 kb RNA and 4 kb
RNA in the cytoplasm.
To examine the impact of the above processes on the
dynamics of viral components in the infected cell, we
started with the analysis of the model in which either
complete or partial export of the Rev protein in the com-
plex with the viral 9 kb and 4 kb RNAs from the nucleus
to the cytoplasm is considered. The maximum number of
the Rev protein molecules that can bind to one viral 9
kb- or 4 kb RNA and be further exported to the cyto-
plasm from the nucleus is estimated of about 12 [51,52].
The interaction of the Rev protein with 9 kb- and 4 kb
RNAs in the cytoplasm was not considered in the model.
The model computations predict that an increase in
the fraction of the Rev molecules exported from the
nucleus to the cytoplasm as a part of the oligomer com-
plex with the intron-containing HIV-1 RNA leads to the
transition from the periodic solution to a steady state
(Figure 4). The oscillatory dynamics persists as long as
the number of the Rev molecules exported to the
cytoplasm is less than 5 (out of 12), whereas larger
numbers result in a steady-state behavior. It should be
noted that an increase in the fraction of exported RNA
molecules leads to a decrease of the amplitude and the
period of the oscillations (Figure 4, upper panel).
However, the negative effect of the nuclear re-export
of the Rev protein on the oscillatory replication
dynamics can be removed by considering the interaction
of the Rev protein with 9 kb RNA and 4 kb RNA in the
cytoplasm, similar to the processes taking place in the
nucleus. The corresponding simulation results for the
complete re-export case (i.e., all the Rev molecules in
the complex with 9 kb RNA and 4 kb RNA are trans-
ported to the cytoplasm from the nucleus) are shown in
Figure 4 (lower panel). One can see that taking account
of the complex formation of Rev with 9 kb RNA and 4
kb RNA in the cytoplasm restores the oscillatory mode.
The restoration of the cycling behavior takes place at a
lower stability of the complex in the cytoplasm as com-
pared to the nucleus.
Figure 4 Dependence of the intracellular Rev protein kinetics on the re-export scale from the nucleus to the cytoplasm. The upper
panel shows the model simulations in which the interaction of the Rev protein with the 9 kb and 4 kb RNAs in cytoplasm is excluded. The
presented curves were computed for various numbers of the Rev protein molecules exported from the nucleus to the cytoplasm due to the
transport of the multimeric complexes <Rev_(i)_9 kb-RNA_nuc> and the <Rev_(i)_4 kb-RNA_nuc> from the nucleus to the cytoplasm, i = 1,...,6.
Curve 1 corresponds to the scenario when all the Rev protein molecules in the i-meric oligomer complex are released in the nuclear pore
complex so that none of the Rev protein molecules enters the cytoplasm; curves 2,3,4,5,6, and 7 represent the Rev protein kinetics characterized
by the export of 1,2,3,4,5 and 6 molecules of the Rev protein to the cytoplasm with the i-meric complex, respectively. The rest of the molecules
of the above complexes as well as of the complexes with a lower number of the Rev proteins are released in the nuclear pore complex to
remain in the nucleus. The lower panel shows the model simulations corresponding to the scenario in which a complete nuclear export of the
Rev molecules to the cytoplasm and the interaction of Rev with the 9 kb and 4 kb RNAs in the cytoplasm take place. The effect of kdis is shown
with curve 1 corresponding to kdis = 8.4 min
-1, curve 2 to kdis = 20 min
-1 and curve 3 to kdis = 50 min
-1. The vertical axis specifies the number of
unbound Rev protein molecules in the nucleus.
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It should be noticed that taking the account of (1) the
re-export process of the Rev protein and (2) the complex
formation of the Rev molecules with 9 kb RNAs and 4 kb
RNAs in the cytoplasm leads to a marked increase of the
period of the oscillatory patterns in the virus replication.
For example, in simulation shown in Figure 3 with no
consideration given to the re-export of the Rev protein
and the complex formation between the Rev molecules
and the 9 kb RNAs and 4 kb RNAs in the cytoplasm, the
period of the oscillations is about 160 to 170 hours. How-
ever, in simulations displayed in Figure 4, the cycle dura-
tion ranges from 200 to 400 hours.
Impact of provirus copy number on the viral components
synthesis kinetics in an activated cell
In the previous sections we studied the model predictions
for the case of one provirus copy (model parameter proV
= 1) in the infected cell. In this case, in the absence of the
Rev protein re-export from the nucleus and the complex
formation of the Rev protein with the 9 kb RNAs and 4 kb
RNAs in the cytoplasm, the steady state pattern of the
virus components replications changes to an oscillatory
dynamics if the activity of the transcription initiation
exceeds the threshold of 5 events per min. Notice that the
above value is still below the maximum transcription
initiation rate which is observed in activated cells as the
data suggests [66]. However, it cannot be excluded that
the transcription initiation activity in some cells remains
below the threshold. The model predicts that in these cells
with one provirus copy a steady state mode of the viral
components synthesis is established. It is known that the
infected cell can harbor more than one provirus [67]. As
the overall efficiency of the transcription initiation
increases with an increase of the proviral copy number, in
the cell which harbor more than one provirus the total
transcription initiation rate can become larger than the
above threshold thus leading to the oscillatory replication
dynamics. Given that the total intensity of the transcrip-
tion initiation according to the model is the product of
ktranscr,ini × proV , then for the transcription initiation para-
meter value kini = 1 events/min the periodic regime takes
place when the number of proviral genomes per cell was
six or more, for the transcription initiation parameter kini
= 2 events/min - three or more proviral genomes
(to ensure ktranscr,ini × proV≥6), etc.
Impact of the abundance of the Rev protein in the
complexes with 9 kb RNA and 4 kb RNA on the viral
components synthesis kinetics in an activated cell
It has been established that the Rev protein can bind to
the HIV-1 9 kb RNAs and 4 kb RNAs on the RRE site
[68]. The number of the proteins molecules that bind to
one RNA molecule can be up to nRev = 12 [52,53]. This
value was used in the simulations presented above. The
model predictions for different values of the parameter
nRev = 12, 10, 8, 6, 4, 3 are shown in Figure 5 (upper
panel). One can clearly see that the oscillatory dynamics
of the viral components synthesis is sensitive to the
value of the above parameter and for nRev < 4 the sys-
tems shifts to a steady state mode. However, if for nRev
= 3 the proviral copy number parameter is increased up
to 10, the oscillatory behavior is restored (Figure 5,
upper panel, curve 1). For nRev = 2 the viral components
production kinetics returns to a steady state mode
(Figure 5, lower panel, curve 2). The oscillatory
dynamics can be regained by an increase of the number
of proviruses to extremely high values which are beyond
the physiological limits. Indeed the model displays a
steady state solution for the proV = 100 copy/cell and
only for the copy number close to proV = 150 copy/cell
a stable periodic solution is predicted. For the lowest
value nRev = 1 the oscillatory solutions were not
revealed.
Overall, the oscillatory dynamics of the viral compo-
nents synthesis in an activated cell is robustly repro-
duced for the following range of the relevant parameter:
4≤ nRev≤12. For nRev = 3 the dynamics depends on the
number of proviruses: for proV = 1 a steady state beha-
vior takes place whereas for proV = 10 an oscillatory
regime is observed. For nRev = 2 the qualitative behavior
is similar to the case nRev = 3, however, for the emer-
gence of the periodic regime much higher number of
the proviral copies is required going beyond the physio-
logical values. No oscillatory dynamics was observed for
nRev = 1.
Impact of the parameters of the transcription
antitermination at the TAR-element on the kinetics of the
viral components synthesis in an activated cell
In the proposed model the antitermination of transcrip-
tion is described by subsystem 3 (see the «Elementary
subsystems of the model» section). The process is char-
acterized by four parameters: the rate constant for the
exit of RNA polymerase II from the pausing at TAR-ele-
ment, kdelay; the rate constant of the antitermination
efficacy, kTat-antiterm,TAR; the forward and reverse rate
constants of the Tat protein binding to the secondary
structure at the TAR-element, kass,Tat-TAR и kdis,Tat-TAR,
(Table 1). The published data suggest that an estimated
ratio Kdis,Tat = kdis,Tat-TAR/kass,Tat-TAR should be around
10 nM [45]. Therefore, the antitermination system is
described in the model by three independent parameters
out of four. The results presented in the above section
were obtained for the specific values of these parameters
given in Table 1. To assess the impact of the parameters
characterizing the transcription antitermination at the
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TAR-element on the model dynamics, a set of simula-
tions was carried out with the parameter values ranging
as given below:
kdelay = 0.25 − 10
−1
min, kTat−antiterm,TAR/kdelay = 1 − 60, kdis,Tat−TAR = 0.1 − 32
−1
min.
The obtained results suggest that the oscillatory mode
is realized in a rather broad range of changes in these
parameters. At the same time it can be noted that there
is exists a definite relationship between the values of
variable parameters. In particularly when the values of
rate constant for the exit of RNA polymerase II from
the pausing at TAR-element, (kdelay) decrease the oscil-
latory regime is realized at the range of higher the
values of constant rates for dissociation of the complex
Tat protein with TAR-element (kdis,Tat-TAR).
Impact of the parameters of oligomerization of the Rev
protein on the RRE site of the intron-containing RNA and
parameters of the complex transport on the viral
components synthesis kinetics
Studies of the interaction of the Rev protein with the
RRE site on the 9 kb and 4 kb HIV-1 RNAs indicate
that the forward and reverse reaction rate constants of
the consecutive binding of four Rev molecules are close
but somewhat different [28]. Therefore, we set the rate
constants for the first 4 sequential reactions as sug-
gested in [28], and for the rest reactions (from 5 to 12)
the parameters were assumed to be equal to that of the
4th reaction.
There are data indicating that the functional efficacy
of the nuclear export complex of Rev with 9 kb- and 4
kb RNA depends on the degree of oligomerization and
the complexes containing 6 to 8 Rev molecules are the
optimal ones [52,53,68]. Based on this observation we
assumed that the dependence of the transport rate con-
stant of the 9 kb- and 4 kb RNA on the number (n) of
the Rev molecules in the complex is a convex unimodal
function with its maximum value at n = 7 (Figure 6b).
The model simulations with the above defined para-
meters for the oligomerization of the Rev protein on the
RRE site of the 9 kb- and 4 kb RNA and the complexes
transport rate constant predict an oscillatory kinetics of
the Tat and Rev proteins synthesis (Figure 6a).
Impact of the 2 kb RNA translation initiation efficacy on
the kinetics of the viral components synthesis in an
activated cell
In previous sections the modelling was based upon the
assumption that for the Tat-Rev mediated regulation of
HIV-1 replication the translation initiation rate con-
stants for 2 kb RNAs encoding the Tat and Rev proteins
Figure 5 Kinetics of the Rev protein in the cell in relation to the oligomerization level in the complex with intron-containing viral
mRNA and the provirus copy number in the genome. The model simulations in the absence of the Rev protein re-export from the nucleus
and the complex formation of the Rev protein with the 9 kb RNAs and 4 kb RNAs in the cytoplasm. Upper panel corresponds to one proviral
copy. Curve 1 corresponds to nRev = 12, curve 2 is for nRev = 10, curve 3 is for nRev = 8, curve 4 is for nRev = 6, curve 5 is for nRev = 4, curve 6 is
for nRev = 3. Lower panel corresponds to 10 proviral copies. Curve 1 is for nRev = 3 and curve 2 is for nRev = 2. The vertical axis specifies the
abundance of the free Rev molecules in the nucleus.
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are about ktransl,ini,Xxx = 10 ini/min,Xxx ∈ {Tat,Rev},
respectively. However, the specific values of the para-
meters for HIV-1 are not known. Therefore, we com-
puted the model solutions for a set of values of the
parameter ktransl,ini,Xxx = 10 ini/min,Xxx ∈ {Tat,Rev}, as
follows: 1, 2, 4, 8, 16, 32, 64 ini/min. For the whole
range of the translation initiation rate constants the
oscillatory dynamics of the viral components synthesis
was preserved.
Impact of the Rev-mRNA stability on the kinetics of the
viral components synthesis in an activated cell
In the above computational experiments with the math-
ematical model of the Tat-Rev regulation of HIV-repli-
cation, the half-life of mRNA encoding the Rev protein
was assumed to be about 4 hours. This estimate was
obtained from the work by Felber et al. [58]. However,
recent studies suggest that the Rev-mRNA half-life is
about 13 hours [59]. We examined the influence of the
parameters k = kdegr,2kb RNA Re v yyy, yyy ∈ {nuc, cyt} on the
dynamics of the viral components synthesis in an acti-
vated cell (Figure 7). For simulations we used the ver-
sion of the model in which the Rev-dependent transport
of the 9 kb RNA and 4 kb RNA from the nucleus to the
cytoplasm leads to the release of the Rev molecules to
the cytoplasm as free molecules (i.e., the re-cyclization
of the Rev protein in the cytoplasm takes place). We did
not consider the binding of the Rev protein to 9 kb
RNA and 4 kb RNA in the cytoplasm. The justification
for considering this scenario is related to the observa-
tion that the version of the model (with the Rev protein
cytoplasmic re-cyclization included) with the parameter
values given in Table 1, predicts a steady state dynamics,
whereas the model version allowing for the re-cycliza-
tion of the Rev protein at the nucleus pore complex
shows an oscillatory behavior for the same parameter
values.
It turned out that in the range [0.0009, 0.0029], min-1,
specifying the lower and upper limits for the parameter
values estimated from the available data [58,59], the
Figure 6 Dynamics of the accumulation of the Tat and Rev proteins in the nucleus depending on the REVn-RNA complex transport
parameters (A). (B) The transport rate constants of the intron-containing HIV-1 RNA depend on the number of the Rev molecules (n) in the
oligomer complexes <Rev_(n)_9 kb-RNA_nuc> and <Rev_(n)_4 kb-RNA_nuc>. This dependence was used for the model simulations.
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Hopf bifurcation takes place for 0.0015<k<0.0016 at
which the steady state becomes unstable and the limit
cycle emanates (Figure 7). The limit cycle exists for k in
the range [0.00009, 0.0012] (indicating a hysteresis phe-
nomenon), and for k<0.00009 min-1 the stable steady
state is realized.
Therefore, the computational analysis of the model
showed that when the re-cyclization of the Rev protein in
the cytoplasm takes place and the Rev protein does not
interact with the 9 kb- and 4 kb mRNA in the cytoplasm
then the oscillatory dynamics is observed for a stable com-
plex Rev-mRNA, i.e., for the values of the respective para-
meters k = kdegr,2kb RNA Re v yyy, yyy ∈ {nuc, cyt}in the range
[0.00009, 0.0012]. For high degradation rate of the Rev-
mRNA complex of about 0.0029 min−1, the oscillatory
behavior is realized only when the rec-cyclization of the
Rev in the nuclear pore complex is considered in the
model.
It should be noted, that in the previously published mod-
els [30-32,34] only a single value of the parameter k was
used, i.e. 0.0029 min-1, and the Rev re-cyclization mechan-
ism was described in accordance with the cytoplasm based
Rev re-cyclization hypothesis. As our model suggest that
this should result into a steady state mode, it is not surpris-
ing that the oscillatory regime has not been predicted.
In general, the computational results suggest the
following:
1) The parameter space region corresponding to the
oscillatory dynamics is rather large;
2) The parameters are not independent with respect to
their impact on the HIV-1 replication system oscillatory
behavior;
3) An increase in the proviral copy number extends
the parameter region in which an oscillatory dynamics
of the virus proteins synthesis takes place;
4) The true values (i.e., the biologically consistent
ones) of the above parameters may well belong to the
oscillatory domains of the model parameters space.
Discussion
In this study we developed the mathematical model of
Tat-Rev-dependent regulatory circuit for HIV-1 replica-
tion consisting of a positive feedback loop for the viral Tat
protein mediated regulation via the antitermination on the
TAR element of the proviral DNA (see, the review [19])
and of a negative regulatory feedback loop via the Rev pro-
tein mediated repression of the intron-containing viral
mRNA splicing [29]. It is known that the presence of both
the positive- and negative regulatory feedback loops is a
prerequisite for the emergence of complex dynamical
behaviors of the system, with an oscillatory dynamics
representing one of them [13-17].
Indeed, the analysis of the model revealed its high
potential with respect to the generation of oscillatory
Figure 7 Impact of the Rev mRNA stability on the kinetics of the viral components synthesis in an activated cell. The curves are
distinguished by the parameters values: curve 1 - k = 0.0009 min-1, curve 2 - k = 0.0014 min-1, curve 3 - k = 0.0015 min-1, curve 4 - k = 0.0016
min-1, k = kdegr,2kb RNA Rev yyy, yyy ∈ {nuc, cyt}. Simulations for the version of the model in which the Rev-dependent transport of 9 kb RNA
and 4 kb RNA from the nucleus to the cytoplasm leads to the release of the RNA bound Rev proteins into the free cytoplasmic fraction.
However, the interaction of Rev with 9 kb- and 4 kb RNAs in the cytoplasm does not take place. The simulations were performed with the
model parameter values listed in Table 1.
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dynamics that was essentially dependent on the Rev pro-
tein re-cyclization mechanism, the stability of its mRNA
and the interaction parameters of the Rev protein with
the RRE site on the intron-containing RNA. These pro-
cesses have been identified and described since only few
years ago [28,36,59]. Therefore, it is not surprising that
in the existing models of the HIV-1 life cycle [30-34]
based on more earlier experimental studies, the exis-
tence of an oscillatory behavior in the virus replication
was not revealed.
Taking into account that the parametric domain cor-
responding to the oscillatory mode of HIV-1 replication
is quite large, we hypothesize that the predicted phe-
nomenon is not a just a modelling artefact but can take
place under certain conditions in the infected cell. One
of the indirect indications in favor of this hypothesis
could be the ability of HIV-1 to establish a long-term
persistent production of the infectious particles in
humans [69]. Although HIV replication occurs both in
CD4 + T-lymphocytes and macrophages, our results on
modeling the HIV intracellular ontogeny should be con-
sidered in the context of the macrophage infection.
Indeed, unlike to T lymphocytes, the macrophages are
more resistant to the cytopathic effects of HIV, and
therefore macrophages are able to sustain the virus pro-
duction for a longer period, thus significantly contribut-
ing to the spread of the virus in the host organism and
its transmission between hosts [70]. This aspect makes
the model predictions biologically relevant since the pre-
dicted oscillations period (up to 10 days) of the HIV
molecular compoments cannot be realized in the cells
with a shorter lifetime.
The developed mathematical model predicts the exis-
tence of oscillatory dynamics in HIV replication at a sin-
gle cell level. To observe a similar dynamics of HIV
growth in cell culture in vitro, a set of experiments spe-
cifically designed to observe the phenomenon is
required using either synchronized cell populations or
individual cells. Indeed, a population averaged measure-
ments may smooth out and lose the appearance of oscil-
lations. Obviously, these types of studies have not been
done yet. However the predicted dynamics is consistent
with the oscillatory patterns of HIV infection exhibited
in the models describing the HIV infection of cell popu-
lations [71] and in tissue cultures [72]. In addition, the
last study predicted the period of oscillations very close
to the one observed in our model. We note that com-
plex patterns of oscillatory behavior in HIV viremia and
CD4+ T Cell Counts have been observed in HIV
infected patients with the between peak intervals of
about 20 days as reported in [73].
We propose that the identified oscillatory dynamics of
HIV-1 replication, which is determined by the specific
characteristics of the structural and functional organization
of the viral genome, can be one of the possible mechanisms
for the maintenance of the prolonged intracellular virus
persistence. Indeed, let us consider the oscillatory behavior
of the viral components from the viewpoint of a biological
advantage. In our discussion we will follow a broadly
accepted paradigm stating that if a specific feature of a bio-
logical system stably persists through many generations
then this feature provides a certain evolutionary advantage
in the struggle for survival. Now, the question is what type
of benefit does the cycling dynamics of the viral compo-
nents production would give to the virus as compared to a
steady state one? In our view, the real advantage is that the
likelihood of the survival of the HIV-1 infected cell popula-
tion should increase.
Consider the population of infected macrophages bear-
ing the provirus in a latent form. Assume that the cell
population gets activated at some time. The activation will
lead to the synthesis of the viral RNAs and proteins, the
assembly and budding of the virus particles in every
infected cell. Such a cell becomes a target for the immune
system with the likelihood of the cell to be recognized by
the cytotoxic T lymphocytes (CTLs) being proportional to
the concentration of the virus-specific antigens that are
expressed on the cell surface by the major histocompatibil-
ity complex (MHC) class I molecules. It is clear that in the
absence of specific hiding mechanisms, the probability of
the infected cell to be recognized and destroyed will be
larger for a higher replication rate of the virus in the cell.
Therefore, after some time most of the infected cells
would become highly prone to killing by the immune sys-
tem and this should lead to a complete elimination of the
infected cell population.
Now assume that the HIV-1 life cycle follows an oscilla-
tory behavior. Then the level of the virus production by
every infected cell will cycle, and in the absence of the
replication cycles synchronization between the cells these
oscillations in the infected cell population will take place
asynchronously. This implies that at any given time only a
fraction of infected cells will be actively producing virus,
with the rest of them staying in a silent mode of the virus
replication. Obviously, the cells characterized by a low
level virus replication will be less recognizable for the
immune system as compared to the actively producing
ones. Thus the immune system will recognize/destroy
only a fraction of infected cells at any given time. There-
fore, the oscillatory dynamics of the viral ontogenesis
should increase the survival of the virus under the selec-
tion pressure by immune system.
Additional mechanism contributing to the long-term
viral persistence in an infected cell may be linked to the
oscillations in the level of the viral regulatory protein
Nef. Indeed, it has been shown that Nef induces a reduc-
tion of the MHC class I molecules at the cell surface via
endocytosis [74,75]. This in turn reduces the efficacy of
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the recognition and killing of the infected cells by CTLs
leading to a latent infection characterized by a long term
low level viral replication.
It should be noted that an advantageous impact of the
oscillatory phenotype of the viral ontogeny on its evolu-
tionary robustness goes beyond the above arguments.
There is another phenomenon which we call the ‘recov-
ery effect’. Indeed, an active viral production by the
infected cell over a long period of time can lead to the
exhaustion of its resources and finally, to death. There-
fore, the alternating phases of high- and low level virus
replication should allow the cell to recover the con-
sumed resources and to circumvent the death. Overall,
this phenotype should increase the survival of the virus
and it is evolutionary advantageous.
The oscillatory dynamics is an inherent feature of
biological systems being a subject of mathematical ana-
lysis and prediction since the early modelling work on
Lotka-Volterra. The mechanisms underlying the emer-
gence of oscillations and their implications should be
explored specifically for a given biological system.
Oscillations are considered as an emergent property of
adaptive biological systems. Following the general dis-
cussion of the potential advantages of oscillations for
evolutionary selection and stabilization as presented
recently in [76], one can propose that as far as the HIV
infection is concerned, the oscillatory behavior of HIV
replication can lead to an increase of the robustness of
the virus persistence in the face of the protective
immune responses.
The study is based on the mathematical model formu-
lated with ODEs assuming that the changes of the reac-
tants are continuous and deterministic. However, at low
numbers of the molecules the consideration of the ran-
domness and discreteness of the interactions needs to
be taken into account. The application of stochastic
modelling approaches to the Tat-Rev regulatory circuit
of HIV-1 replication deserves a separate investigation.
In addition, we would like to note that the Tat-Rev
regulatory system of HIV replication machinery contains
all the structural motifs necessary for the emergence of
the chaotic dynamics of the synthesis of viral compo-
nents, including: the regulatory circuit of HIV-1 replica-
tion based on two feedback loops, one loop
implementing a positive feedback regulation thus acting
as an activator and the second one - a negative feedback
regulation functioning as a repressor and a time lag in
the synthesis of the regulatory factors, resulting from
the fundamental processes of transcription, splicing,
transport and translation [77-81]. Although in the ana-
lyzed domain of the model parameters the modelled sys-
tem did not demonstrate chaotic regimes, we believe
that the issue of an irregular behavior is very challenging
and deserves further investigation.
The modelling results are obtained under a simplifying
assumption that the immune system does not affect
directly the infected cells. However, the interaction
between the infected cells and the other cells of the
immune system is a fundamental question. We plan to
address this complex issue in future study.
Conclusions
The developed mathematical model of HIV-1 replication
predicts an oscillatory dynamics of the viral components
synthesis in an infected cells for a broad range of the
model parameters that results from the specific features
of the structural-functional organization of the viral gen-
ome. The major processes underlying the emergence of
the oscillations are the Rev protein re-cyclization at the
nuclear pore complex, described by [35,36], and the
robustness of the Rev-mRNA complex [59]. The biologi-
cal advantage of the oscillatory dynamics in the intracel-
lular synthesis of the viral components can be linked to
the general evolutionary trend of developing mechan-
isms enabling the survival of a fraction of the infected
target cells under the permanent pressure by the host
immune system. This type of the ontogenesis dynamics,
independently of other specific protection mechanisms
evolved by the virus, can contribute to the long-term
persistent production of the virus in the human organ-
ism, which is a remarkable property of HIV-1 [69].
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